4//SEC Filing
Rubini Jonathan Brian 4
Accession 0001213900-20-045804
CIK 0001218683other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 5:22 PM ET
Size
20.3 KB
Accession
0001213900-20-045804
Insider Transaction Report
Form 4
Rubini Jonathan Brian
10% Owner
Transactions
- Exercise of In-Money
Warrant (right to buy)
2020-12-29−350,000→ 0 totalExercise: $0.16From: 2019-04-21Exp: 2023-10-23→ Common Stock (350,000 underlying) - Sale
Common Stock
2020-12-29−2,692→ 6,843,170 total - Exercise of In-Money
Warrant (right to buy)
2020-12-29−259,037→ 0 totalExercise: $1.97From: 2017-11-16Exp: 2020-12-31→ Common Stock (259,037 underlying) - Exercise of In-Money
Common Stock
2020-12-29+350,000→ 6,845,862 total - Sale
Common Stock
2020-12-29−33,951→ 6,495,862 total - Exercise of In-Money
Common Stock
2020-12-29+4,074,074→ 6,529,813 total - Exercise of In-Money
Warrant (right to buy)
2020-12-29−4,074,074→ 0 totalExercise: $0.27Exp: 2024-12-19→ Common Stock (4,074,074 underlying) - Sale
Common Stock
2020-12-29−2,159→ 7,100,048 total - Exercise of In-Money
Common Stock
2020-12-29+259,037→ 7,102,207 total
Footnotes (6)
- [F1]On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price.
- [F2]On December 29, 2020 the reporting person exercised a warrant to purchase 4,074,074 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 33,951 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 4,040,123 shares.
- [F3]On December 29, 2020 the reporting person exercised a warrant to purchase 350,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 2,692 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 347,308 shares.
- [F4]On December 29, 2020 the reporting person exercised a warrant to purchase 259,037 shares of the registrant's common stock for $1.97 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 2,159 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 256,878 shares.
- [F5]Exercisable five days following the public announcement of positive clinical data results for LO2A.
- [F6]The expiration date was extended from 11/16/2029 to 12/31/2020.
Documents
Issuer
Wize Pharma, Inc.
CIK 0001218683
Entity typeother
Related Parties
1- filerCIK 0001723667
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 5:22 PM ET
- Size
- 20.3 KB